Slovakia Approves Treatment Coverage for Friedreich's Ataxia Patients

Slovakia's Ministry of Health has approved coverage for a treatment for Friedreich's ataxia, making the therapy accessible to patients with this rare genetic disorder in the country. The approval followed negotiations between the Ministry of Health and the drug's registration holder, with both parties reaching an agreement on reimbursement terms through a Managed Entry Agreement (MEA) contract earlier this year. Friedreich's ataxia is a progressive neurological condition that affects movement and coordination, and the availability of covered treatment represents a significant development for Slovak patients with this rare disease.